| First Author | Kang HS | Year | 2011 |
| Journal | Physiol Genomics | Volume | 43 |
| Issue | 13 | Pages | 818-28 |
| PubMed ID | 21540300 | Mgi Jnum | J:174804 |
| Mgi Id | MGI:5141189 | Doi | 10.1152/physiolgenomics.00206.2010 |
| Citation | Kang HS, et al. (2011) Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis. Physiol Genomics 43(13):818-28 |
| abstractText | Retinoid-related orphan receptor (ROR)alpha4 is the major RORalpha isoform expressed in adipose tissues and liver. In this study we demonstrate that RORalpha-deficient staggerer mice (RORalpha(sg/sg)) fed with a high-fat diet (HFD) exhibited reduced adiposity and hepatic triglyceride levels compared with wild-type (WT) littermates and were resistant to the development of hepatic steatosis, adipose-associated inflammation, and insulin resistance. Gene expression profiling showed that many genes involved in triglyceride synthesis and storage, including Cidec, Cidea, and Mogat1, were expressed at much lower levels in liver of RORalpha(sg/sg) mice. In contrast, overexpression of RORalpha in mouse hepatoma Hepa1-6 cells significantly increased the expression of genes that were repressed in RORalpha(sg/sg) liver, including Sult1b1, Adfp, Cidea, and ApoA4. ChIP and promoter analysis suggested that several of these genes were regulated directly by RORalpha. In addition to reduced lipid accumulation, inflammation was greatly diminished in white adipose tissue (WAT) of RORalpha(sg/sg) mice fed with an HFD. The infiltration of macrophages and the expression of many immune response and proinflammatory genes, including those encoding various chemo/cytokines, Toll-like receptors, and TNF signaling proteins, were significantly reduced in RORalpha(sg/sg) WAT. Moreover, RORalpha(sg/sg) mice fed with an HFD were protected from the development of insulin resistance. RORalpha(sg/sg) mice consumed more oxygen and produced more carbon dioxide, suggesting increased energy expenditure in this genotype. Our study indicates that RORalpha plays a critical role in the regulation of several aspects of metabolic syndrome. Therefore, RORalpha may provide a novel therapeutic target in the management of obesity and associated metabolic diseases. |
